Completed PHASE1 INTERVENTIONAL 2-arm NCT03512860

Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study

An Open-label, Two-way Cross-over Study to Determine the Effect of Multiple Doses of Valproic Acid on the Pharmacokinetics and Safety of a Single Oral Dose of Estetrol/Drospirenone in Healthy Female Subjects

Sponsor: Estetra

Conditions Contraception

Interventions E4/DRSP VAL

Updated 5 times since 2018 Last updated: Dec 13, 2018 Started: Apr 12, 2018 Primary completion: Oct 8, 2018 Completion: Oct 8, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Contraception, this trial is completed. The trial is conducted by Estetra and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2019 — Jan 2021 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Jun 2018 — Jan 2019 [monthly]

Recruiting PHASE1

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Estetra
Quotient Sciences

Data source: Estetra

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ruddington, United Kingdom